RE:Companies now seek to moderate TME to expand PD-(L)1 effect
A very interesting article admtting that PD-1/PD-L1 is not enough.
CD8 is mentioned on slide 25 of the current presentation, and also in Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus, and elsewhere I am sure. I do not really know what it means, and have come to the conclusion that this whole subject is too complex for most. Conclusion: this is so complex, we shall have to wait for a news release that explains clearly and definitively what is going on, and that is not something it seems that is easy to present. GLTA.
Sill very positive from a layman's perspective, but this may take more time.